Figure 3From: Management of patients with uncontrolled arterial hypertension – the role of electronic compliance monitoring, 24-h ambulatory blood pressure monitoring and Candesartan/HCTObserved Daily probability of intake preceding the week 4 visit. Difference between the adherence in the controlled patients and the non controlled patients: the adherence of non controlled patients was significant lower and the decrease steeper.Back to article page